Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-190017
Filing Date
2021-06-14
Accepted
2021-06-14 16:06:04
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d186690d424b5.htm 424B5 493837
2 GRAPHIC g186690g1031084921394.jpg GRAPHIC 2981
3 GRAPHIC g186690g74s49.jpg GRAPHIC 6992
4 GRAPHIC g186690snap2.jpg GRAPHIC 10238
  Complete submission text file 0001193125-21-190017.txt   523180
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249848 | Film No.: 211014659
SIC: 2834 Pharmaceutical Preparations